Prediction: This Will Be the Best Pharmaceutical Stock to Own Over the Next 10 Years

Eli Lilly is one of the most innovative pharmaceutical companies right now.So far in 2024, the healthcare sector has returned 8.5%. This is roughly on par with the long-term average return of the S&P 500. While that's not too shabby, growth investors may be looking for something a little more enticing.Within the broader healthcare sector, the drug manufacturers market has generated a return of 14.3% so far in 2024 and 17.3% over the last year. One of the biggest players among drug manufacturers is Eli Lilly ...